BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 34681182)

  • 1. Carfilzomib activates ER stress and JNK/p38 MAPK signaling to promote apoptosis in hepatocellular carcinoma cells.
    Deng Y; Li Y; Yang M; Gao Y; Luo X; Chen H; Guo M; Yang X; Liu Y; He J; Lu B; Liu N
    Acta Biochim Biophys Sin (Shanghai); 2024 Apr; ():. PubMed ID: 38591121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Cancer Effects of 3, 3'-Diindolylmethane on Human Hepatocellular Carcinoma Cells Is Enhanced by Calcium Ionophore: The Role of Cytosolic Ca
    Jiang Y; Fang Y; Ye Y; Xu X; Wang B; Gu J; Aschner M; Chen J; Lu R
    Front Pharmacol; 2019; 10():1167. PubMed ID: 31649538
    [No Abstract]   [Full Text] [Related]  

  • 3. Retraction Note: BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway.
    Feng PC; Ke XF; Kuang HL; Pan LL; Ye Q; Wu JB
    Stem Cell Res Ther; 2022 Apr; 13(1):154. PubMed ID: 35395807
    [No Abstract]   [Full Text] [Related]  

  • 4. Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer.
    Liu W; Wang Y; Xia L; Li J
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistomycin Inhibits Wnt/β-Catenin Signaling to Induce the Apoptotic Death of Human Colorectal Cancer Cells.
    Zhu Y; Zhang E; Gao H; Shang C; Yin M; Ma M; Liu Y; Zhang X; Li X
    Mar Drugs; 2023 Nov; 21(12):. PubMed ID: 38132944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistomycin Suppresses Prostate Cancer Cell Growth by Instigating Oxidative Stress, Mitochondrial Apoptosis, and Cell Cycle Arrest.
    Aloufi AS; Habotta OA; Abdelfattah MS; Habib MN; Omran MM; Ali SA; Abdel Moneim AE; Korany SM; Alrajhi AM
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistomycin Induced Apoptosis and Cycle Arrest in Human Hepatocellular Carcinoma Cells by Activating p38 MAPK Pathway In Vitro and In Vivo.
    Han Z; Zhao X; Zhang E; Ma J; Zhang H; Li J; Xie W; Li X
    Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway.
    Li L; Zheng BB; Ma LS; Sun X; Chang JJ; Xie WD; Li X
    Acta Pharmacol Sin; 2014 Oct; 35(10):1311-22. PubMed ID: 25176399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma.
    Gao Y; Lin LP; Zhu CH; Chen Y; Hou YT; Ding J
    Cancer Biol Ther; 2006 Aug; 5(8):978-85. PubMed ID: 16855382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspafilioside B induces G2/M cell cycle arrest and apoptosis by up-regulating H-Ras and N-Ras via ERK and p38 MAPK signaling pathways in human hepatoma HepG2 cells.
    Liu W; Ning R; Chen RN; Huang XF; Dai QS; Hu JH; Wang YW; Wu LL; Xiong J; Hu G; Guo QL; Yang J; Wang H
    Mol Carcinog; 2016 May; 55(5):440-57. PubMed ID: 25683703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the p38 MAPK signaling pathway in S-phase cell-cycle arrest induced by Furazolidone in human hepatoma G2 cells.
    Sun Y; Tang S; Jin X; Zhang C; Zhao W; Xiao X
    J Appl Toxicol; 2013 Dec; 33(12):1500-5. PubMed ID: 23112108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
    Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H
    Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.